Margarita Cancio is an Infectious Disease physician. OpenAlex indexes 18 publications with 374 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20258 payments
- Gilead Sciences, Inc.Program year20258 payments
- Astellas Pharma US IncProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor9.9%Juluca34%Tivicay22%Dovato19%Isentress17%Cabenuva9%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor4.3%Triumeq61%Descovy39%Part D<11 patients+ 10 more classes in this area
Cardiovascular
26.5%Statin10%Rosuvastatin Calcium50%Atorvastatin Calcium17%Pravastatin Sodium16%Livalo9%Pitavastatin Calcium9%Part D<11 patientsAngiotensin receptor blocker (ARB)4.8%Losartan Potassium100%Part D≥11 patients+ 6 more classes in this area
Nervous system
14.5%Benzodiazepine7%Clonazepam33%Temazepam24%Alprazolam23%Lorazepam21%Part D<11 patientsSSRI3.6%Sertraline Hcl71%Escitalopram Oxalate29%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
Open Forum Infectious Diseases
2021 - Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions
Infection Control and Hospital Epidemiology
2012 - Prevention of Infection Caused by Gram-Positive Bacteria in the Bloodstream and Lungs
Infection Control and Hospital Epidemiology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”